HRT FINANCIAL LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7
-94.5%
19,313
-93.2%
0.00%
-100.0%
Q2 2023$127
-99.9%
285,122
+841.0%
0.00%0.0%
Q4 2021$151,000
-60.6%
30,300
-43.4%
0.00%
-50.0%
Q3 2021$383,000
-45.1%
53,560
-28.9%
0.00%
-66.7%
Q2 2021$697,000
+97.5%
75,292
-29.8%
0.01%
-60.0%
Q4 2019$353,000
+178.0%
107,238
+586.3%
0.02%
-75.0%
Q2 2015$127,00015,6260.06%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders